Transaction in Own Shares • Feb 8, 2018
Transaction in Own Shares
Open in ViewerOpens in native device viewer
Sofia, Bulgaria, February 8, 2018 - Sopharma AD (3JR: "BSE-Sofia" AD, SPH: Warsaw Stock Exchange) notifies that on 29 December 2017 the Company bought 1186 own shares representing 0.00088% of the share capital of the Company, at a total value of 5080.82 BGN on the Bulgarian Stock Exchange, the average price per share was 4.28 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 8 904 000, representing 6.61% of the share capital of the Company.
85 years tradition and modern approach – modern production, European quality standards, corporate social responsibility. Sopharma has an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer. Sopharma AD continuously invests in technologies, innovation, research and science. We establish a constant and effective dialogue with all the actors in the pharmaceutical industry that contribute to the improvement of the health care system.
The company produces and markets medicinal substances and dosage forms; conducts research, engineering and implementation activities in the field of phytochemistry, chemistry and pharmaceuticals. Sopharma AD provides services related to production, as well as to ancillary and service activities.
The Company has a portfolio of more than 210 products: mainly generics and 15 original products, of which 12 products are phyto-based.
Sofia, Bulgaria www.sopharmagroup.com
5 Lachezar Stanchev Str. tel: +359 (0) 2 4055 200; +359 (0) 8134 200 Sopharma Business Towers, Tower А fax: +359 (0) 2 4055 141; +359 (0) 8134 141
Sopharma Group is a vertically integrated healthcare business that operates in important sectors such as pharmaceuticals production, hospital supplies, pharmaceutical distribution (GDP standardized) and others. Sopharma and its production subsidiaries have 12 pharmaceutical plants in Bulgaria, complying with EU requirements – GMP and a factory in Ukraine certified by local authorities.
Sofia, Bulgaria www.sopharmagroup.com
5 Lachezar Stanchev Str. tel: +359 (0) 2 4055 200; +359 (0) 8134 200 Sopharma Business Towers, Tower А fax: +359 (0) 2 4055 141; +359 (0) 8134 141
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.